RESEARCH-USE BIOSIMILAR ANTIBODY

Dectrekumab

Monoclonal antibody · IgG1

IL13IgG1RUO

Dectrekumab (QAX576) is a human monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research.

TARGETIL13
YMonoclonal antibody
CATALOGSC-BS-632
CATALOG NUMBERSC-BS-632
MOLECULAR WEIGHTApprox. 146.02 kDa
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Dectrekumab (QAX576) is a human monoclonal antibody that targets IL-13. Dectrekumab significantly improves intraepithelial esophageal eosinophil counts and dysregulated esophageal disease-related transcripts with Eosinophilic esophagitis (EoE) in a sustained manner and can be used for inflammation and immunology related research.

Dectrekumab is a recombinant research-use antibody directed against IL13.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte